Smith & Nephew PLC
SNN
Company Profile
Business description
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Contact
Hatters Lane
Building 5, Croxley Park
Watford Hertfordshire WD18 8YE
GBRT: +44 1923477100
E: investorrelations.global@smith-nephew.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2024
Employees
18,452
Stocks News & Analysis
stocks
11 ASX stocks offering great value right now
These high-quality companies are our top picks for investors wanting to boost their domestic exposure.
stocks
ASX stock gets a moat upgrade
Morningstar analyst Mark Taylor upgrades Seven Group Holdings' moat and fair value rating.
stocks
Is CBA attractive after earnings?
The shares of Australia’s largest bank have risen 20% in the last year.
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,028.90 | 33.20 | 0.42% |
| CAC 40 | 8,225.79 | 16.51 | 0.20% |
| DAX 40 | 18,716.42 | 25.80 | -0.14% |
| Dow JONES (US) | 39,558.11 | 126.60 | 0.32% |
| FTSE 100 | 8,428.13 | 13.14 | 0.16% |
| HKSE | 19,073.71 | 41.35 | -0.22% |
| NASDAQ | 16,511.18 | 122.94 | 0.75% |
| Nikkei 225 | 38,433.36 | 77.30 | 0.20% |
| NZX 50 Index | 11,543.35 | 74.74 | -0.64% |
| S&P 500 | 5,246.68 | 25.26 | 0.48% |
| S&P/ASX 200 | 7,762.80 | 36.00 | 0.47% |
| SSE Composite Index | 3,145.77 | 2.25 | -0.07% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Sayona Mining Ltd SYA | 0.05 | 0.00 | -1.09% |
| Pantoro Ltd PNR | 0.08 | 0.00 | 1.88% |
| Core Lithium Ltd CXO | 0.15 | 0.01 | -6.25% |
| Renascor Resources Ltd RNU | 0.13 | 0.03 | 25.00% |
| Imugene Ltd IMU | 0.07 | 0.00 | -0.70% |
| Arafura Rare Earths Ltd ARU | 0.20 | 0.01 | 6.76% |
| Capitol Health Ltd CAJ | 0.26 | 0.01 | 5.10% |
| Pilbara Minerals Ltd PLS | 3.98 | 0.01 | 0.25% |
| Medibank Private Ltd MPL | 3.75 | 0.03 | 0.67% |
| South32 Ltd S32 | 3.67 | 0.05 | 1.38% |